Zevra Therapeutics, Inc. (ZVRA)

NMS – Real Time Price. Currency in USD

11.45

+0.12 (1.01%)

Market open: Aug 12, 2026, 3:59 PM EDT

11.77

+0.43 (3.79%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

106M

24M

27M

10M

Cost of goods sold

-21M

-20M

-4M

-1M

Gross Profit

86M

24M

Operating expenses (excl. COGS)

-90M

-91M

-73M

-34M

Operating Income

-4M

-87M

-50M

-25M

Non-operating income, total

91M

-3M

-2M

Pretax income

87M

-90M

-46M

-27M

Equity in earnings

Taxes

-3M

-15M

33K

Non-controlling/minority interest

After tax other income/expense

-6M

Net income before discontinued operations

78M

-106M

-46M

-27M

Discontinued operations

Net income

78M

-106M

-46M

-27M

Dilution adjustment

Preferred dividends

Zevra Therapeutics, Inc. (ZVRA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Zevra Therapeutics, Inc. (ZVRA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Zevra Therapeutics, Inc. (ZVRA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Zevra Therapeutics, Inc. (ZVRA)

Income Statement (Annual)

Income Statement (Annual)